New Ray Medicine International Holding Limited (New Ray Medic) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming a stable capital structure throughout the month.

Authorised Share Capital • Authorised share capital held steady at 15.00 billion ordinary shares with a par value of HKD 0.01, representing HKD 150.00 million in nominal terms. No changes were recorded during the month.

Issued Share Capital and Public Float • Issued ordinary shares (excluding treasury shares) remained unchanged at 200.62 million. • The company held no treasury shares, leaving total issued shares also at 200.62 million. • New Ray Medic affirmed compliance with the Hong Kong Stock Exchange’s 25% minimum public-float requirement.

Share Option Position • Under the Share Option Scheme adopted on 25 October 2013, 12.82 million options were outstanding at both the beginning and end of March 2026. • No options were exercised, no new shares were issued, and the company raised no proceeds from option conversions during the month.

Other Equity Instruments • The company reported no warrants, convertible securities, or additional share-issuance arrangements. • There were no other movements in issued or treasury shares.

Regulatory Confirmation • The filing, signed by Company Secretary Ng Yat Sing on 2 April 2026, states that all listing-rule and legal requirements related to any past issuances remain satisfied.

With no equity movements in March 2026, New Ray Medic’s share count, authorised capital, and public float remain consistent, while a modest pool of unexercised options under the 2013 scheme continues to represent potential future dilution of up to 12.82 million shares.